Introduction
Idiopathic acquired aplastic anemia (AAA) is due to an immune destruction of hematopoietic stem cells in the bone marrow. Whereas events initiating immune aggression have not been fully clarified, pathogenic steps more closely associated with damage of marrow cells are better understood. 1, 2 Current evidence indicates that auto reactive T cells, activated by different stimuli, release myelosuppressive cytokines including TNF-α and IFN-γ which cause hematopoietic stem cell death by blocking mitosis and increasing apoptosis [3] [4] [5] [6] [7] pointing to these cytokines as late effectors of the hematopoietic cell depletion of idiopathic AAA. In the absence of an HLA matched sibling donor, combined immunosuppression (IS) with ATG and cyclosporine A is the first-line treatment producing a response rate of about 80%. 1, 8 However, responsive patients retain a more defective hematopoiesis compared to transplanted and normal individuals 9 and have an up to 30% risk of non-response/disease recurrence. [10] [11] [12] Mechanisms underlying the risk of relapse have not been fully clarified at the level of marrow biology. It can be postulated that treatment does not sufficiently clear TNF-α and IFN-γ, the late mediators of the hematopoietic damage, from the marrow of responding patients. To explore this hypothesis we assessed, in the marrow CD3 + cells of idiopathic AAA patients treated with combined IS, the intracellular expression of TNF-α, IFN-γ and IL4, as effectors involved in the immune response, and the effect of in vitro block of TNF-α and IFN-γ on the growth of hematopoietic progenitors.
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Cytokine expression assessed by flow cytometry in 53 acquired aplastic anemia patients before and after combined immunosuppression (EBMT WPSAA protocols) showed that CD3 + marrow cells containing TNF-α, IFN-γ and IL4 were similar in subjects with disease at onset (DO) and responsive to treatment who had more CD3 
Design and Methods

Cytokine expression in CD3
+ cells assessed at diagnosis and in responders Flow cytometry analysis of intracellular expression of TNF-α, IFN-γ, IL-4 in marrow CD3
+ cells was performed as described elsewhere 14 and is detailed in the Online Supplementary Appendix 2.
Cytokine blockade in marrow culture
We assessed the growth of BFU-e in the absence and in the presence of agents blocking TNF-α and/or IFN-γ on 31 marrow samples obtained from patients studied for cytokine expression. Controls were those of the above study. Committed progenitor assays was performed as described elsewhere 14 and as detailed in the Online Supplementary Appendix 3.
Cytokine expression in CD3
+ cells in patients with sampling at diagnosis and during follow-up Normal controls were healthy voluntary donors. Informed consent was obtained from parents of patients and controls or, whenever eligible, from patients and controls themselves in accordance with the Helsinki declaration of principles. Bone marrow was taken from the patients during aspirations required for diagnosis or disease monitoring.
Statistics
Due to small sample size and non-normal distribution, quantitative data were described as medians and comparisons were performed by means of non-parametric tests (Friedman, Wilcoxon, Kruskal Wallis and the MannWhitney U tests) using Bonferroni correction (see the Online Supplementary Appendix 4).
Results and Discussion
Cytokine expression in CD3 + cells assessed at diagnosis and in responders
Absolute CD3
+ cells in DO were higher than in controls (p=0.003) but similar (p=0.776) in RT and normal subjects. Consistently, DO had more CD3 + cells than RT patients (p= 0.011). CD3 + /TNF-α + cells in both RT and DO subjects were more numerous than in normal controls (p=0.001 and <0.001, respectively) whereas the difference between DO and RT was not significant (p= 0.083) ( Table 1) . CD3 + /IFN-γ + cells were more numerous in RT (p=0.001) and DO (p<0.001) than in normal subjects but similar among each other (p=0.592) ( Table 1) .
After Bonferroni correction, CD3 + /IL4 + cells were similar in paired comparisons between normal controls and RT (p=0.240), RT and DO (p=0.370), and DO and normal subjects (p=0.067) ( Table 1) .
Cytokine expression analyzed by the presence/absence of treatment with G-CSF, transfusions, CsA and steroids showed no differences in either RT or DO patients except for the following: (i) CD3 + /IFN-γ + cells were higher (p=0.026) in RT subjects who received (3 patients) versus those not receiving (24 patients) steroids; (ii) CD3 + /TNF-α + cells were more numerous in DO subjects not receiving (25 patients) versus those receiving (8 patients) steroids (p=0.0428).
Cytokine blockade in marrow culture
BFU-e growth without the addition of etanercept and/or IFN-γ blocking antibody, was different in controls, compared to RT, and DO (p=0.0001). DO patients had remarkably less colonies versus both RT (p<0.001) and normal controls (p=0.001), whereas progenitor growth was similar in RT and normal subjects (p=0.551) ( Table 1) .
Blockade of TNF-α or/and IFN-γ in culture of normal controls' MNCs, did not increase absolute number of BFU-e over baseline. In RT patients, BFU-e became significantly higher than baseline after block of TNF-α, (p=0.010), of IFN-γ (p=0.003) and double block (p=0.003) ( Table 1) .
In DO patients, colonies were also significantly more numerous over baseline after block of TNF-α (p=0.034), of IFN-γ (p=0.009) and of TNF-α and IFN-γ (p=0.007) ( Table 1) .
These data show that neutralization of TNF-α and IFN-γ increases the number of BFU-e over baseline, indicating that these cytokines inhibit erythropoiesis in vitro in both DO and RT patients. To better understand which cytokine removal was more effective in increasing in vitro erythropoiesis, we compared the increment of growth of BFU-e after cytokine block in the three groups. BFU-e increment in RT patients after TNF-α blockade was significantly greater than in normal controls (p=0.04), whereas in DO patients it was not (p=0.352). No significant difference occurred between RT and DO (p=0.162) ( Figure 1A) . Blockade of IFN-γ gave a greater, but not significant, increment in RT subjects (p=0. Figure 1B) . After double block, the increment in the RT group was significantly greater (p=0.019) than in normal controls, whereas in DO patients was not (p=0.067). No significant increment was found in RT vs. DO subjects (p=0.414) ( Figure 1C + cells at RET compared to diagnosis whereas non responders did (p=0.005), possibly reflecting a prevalent Th1 cell expansion at the expense of Th2 cells in these patients.
Noteworthy, in agreement with data of the first study, CD3
+ cells containing TNF-α + or IFN-γ + at RET were significantly more numerous than in normal subjects not only in non responders but also in responders (Figure 2 C  and F) . There was no difference between responders and non responders either at diagnosis or at RET for any cellular subset (Online Supplementary Appendix 6) .
In this project we investigated, in different phases of disease, the changes in myelosuppressive cytokines TNF-α and IFN-γ, the final mediators of the damage on marrow hematopoietic cells in idiopathic AAA and of IL4, a cytokine characterizing Th2 polarization of T cells.
Intracytoplasmic expression indicates that in RT patients, myelosuppressive cytokine load was significantly greater than in normal controls. On the contrary, IL4 was not differentially expressed in patients' subgroups and in normal controls, suggesting a non-primary involvement of this cytokine in the pathogenesis of the disease. The expression of inflammatory cytokines might be influenced by transfusions, steroids, CsA and G-CSF. 15, 16 In this study, we did not find any effect of these factors except for some influence of steroids on restricted cell subsets and in small subgroups. The limited size of some groups does not allow firm conclusions to be drawn but our finding, consistent with others from the literature, 5, 17 seems to confirm that intralymphocytic TNF-α and IFN-γ overexpression is related to the disease.
Cytokine blockade study showed that in the same patients in whose marrow cells TNF-α or IFN-γ were over-expressed, the neutralization of these effectors enhanced the growth of erythroid progenitors. This is a new finding confirming that TNF-α and IFN-γ contribute to erythroid failure of AAA. [3] [4] [5] [6] [7] In DO patients, BFU-e increment was not significant with any cytokine block, probably due to the severely reduced stem cell potential as witnessed by the low number of colonies of these patients compared to normal and RT groups. In RT patients, TNF-α block was the most effective in increasing erythropoiesis in vitro (Figure 1 A and C) suggesting that in the marrow of these subjects an important excess of this cytokine persists. This does not manifestly harm erythropoiesis probably because of compensatory proliferation of stem cell compartment as witnessed by BFU-e numbers comparable to normal controls. It is possible that in case of re-activation of the autoimmune attack this smoldering activity becomes effective and damages hematopoietic cells which then results in an overt relapse.
Prospective study of cytokine expression suggests that responders and non responders can not be differentiated by the number of marrow CD3 5 ). This is in contrast with other data, 3 indicating that at diagnosis responders to IS displayed CD8 + /IFN-γ + cells whereas non responders had CD8 + staining negative for IFN-γ. There are differences between the two studies, + /IFN-γ + cells at RET versus diagnosis more efficiently than non responders, it is of note that myelosuppressive cytokine load of responders at RET was still greater than in normal controls. Although aspiration technique might have influenced the number of cells/mL, the consistency of cytokine expression in first and in paired sample studies seems to attenuate the role of this potentially disturbing effect. Overall, these new findings, consistent with results of BFU-e study, confirm that IS does not clear excess TNF-α and IFN-γ from the marrow of patients with good outcome. It can then be speculated that a more intense combined IS including targeted agent against key molecules like TNF-α, might reduce the harmful potential on the marrow of AAA patients, increase response to IS and, hopefully, diminish relapse risk. This study confirms that TNF-α and IFN-γ have an important role in the pathogenesis of AAA, and indicates that these cytokines decline to a lower extent in non responders than in responders to IS in whose marrow they are not cleared to normal but still persist and reduce erythropoiesis. This might contribute to relapse in case of immune attack re-activation and raises the hypothesis of the clinical usefulness of adopting additional cytokine blockade aiming to reduce the risk of marrow failure recurrence.
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